secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPT Therapeutics, Inc. (—)
CIK:        0001673772
Form:       8-K
Filed at:   2024-07-19T23:59:59+00:00
Accession:  0000950170-24-084991
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

RAPT Therapeutics cuts 40% of workforce (47 employees) to conserve cash, expects $0.9M charge
--------------------------------------------------------------------------------

- Board approved workforce reduction of 47 people, representing ~40% of total headcount.
- Company expects ~$0.9 million in restructuring charges from severance, benefits, and related costs.
- Majority of cash payments and execution expected by end of Q3 2024.
- Severance benefits contingent on affected employees signing general release of claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1673772/000095017024084991/0000950170-24-084991-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1673772/000095017024084991/rapt-20240716.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-084991

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer